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The history of the testis and testosterone 
treatment 
E. NIESCHLAG 
Institute of Reproductive Medicine of the University 
D-48129 M~nster, Germany 
Email: Eberhard.Nieschlag@ukmuenster.de 
The biological effects of the testes and testosterone (T) are 
known since antiquity. Aristotle (384-322 BC) knew the effects 
of castration and his hypothesis on fertilization is one of the 
first scientific encounters in reproductive biology. Over 
centuries castration has been performed as punishment, 
but also to preserve the soprano voices of prepubertal boys. 
The Chinese imperial (and other oriental) courts employed 
castrates as overseers of harems; the last of the Chinese 
eunuchs died in 1996. 
The era of testis transplantation and organotherapy was 
initiated by John Hunter in London who transplanted testes 
into capons in 1786. The intention of his experiments was 
to prove the "vital principle" as the basis for modern 
transplantation medicine, but Hunter did not consider 
endocrine aspects. Adolph Berthold postulated internal 
secretion from his testicular transplantation experiments in 
1849 in G6ttingen and is thus considered the father of 
endocrinology. Following his observations, testicular 
preparations were used for therapy, popularised by self- 
experiments by Charles-Edouard Brown-Sequard in Paris 
(1889), which can at best have had placebo effects. 
Nevertheless, testis preparations were consumed until quite 
recently for the enhancement of virility. In the 1920s Sergio 
Voronoff transplanted testes from animals to men, but their 
effectiveness was disproved by the Royal Society of Medicine 
in 1927. Experimentation with testicular transplantation 
continued to be popular in Russia. Today testicular 
transplantation is being refined by stem cell research and 
germ cell transplantation9 
Modern androgen therapy started in 1935 when Ernest 
Lacquer isolated T from bull testes in Amsterdam. In the 
same year T was then chemically synthesized independently 
by Adolf Butenandt in G6ttingen and Leopold Ruzicka in 
Basel. Since T was ineffective orally it was either compressed 
into subcutaneous pellets or was used orally as 17_-methyl 
T, now obsolete because of liver toxicicity. In the 1950s 
longer-acting injectable T enanthate became the preferred 
therapeutic modality. In the 1950s and 1960s research 
concentrated on the chemical modification of androgens in 
order to emphasise their anabolic effects. Although anabolic 
steroids have largely disappeared from clinical medicine, 
they continue to live an illegal life for doping in athletics. In 
the 1970s the orally effective T undecanoate was added to 
the spectrum of preparations. In 1992 WHO, NIH and FDA 
postulated preparations of natural T mimicking physiological 
serum levels, a demand first met by a transdermal scrotal 
film. Non-scrotal skin patches followed and finally in 2000 
transdermal T gels became available. The most recent 
additions to T substitution therapy, the short-acting buccal T 
and the long-acting injectable T undecanoate, also fulfil the 
demand for physiological serum levels. 
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Reproductive epigenetics and transgenerational 
toxicity 
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The term 'epigenetics' refers to heritable non-sequence 
based mechanisms that regulate gene activity. Three main 
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types of mechanisms, including DNA methylation, RNA- 
associated silencing and histone modifications have been 
associated with the epigenetic silencing of genes. To date, the 
most well studied 
DNA modification associated with the modulation of gene 
activity is methylation of cytosine residues within CpG 
dinucleotides occurring at about 25 million sites throughout 
the genome. DNA methylation plays a role in regulating genes 
during development and has been implicated in gene 
regulation, genomic imprinting (variation in the expression of 
a gene according to its maternal or paternal origin), and X 
inactivation. Abnormalities in DNA methylation have been 
linked to cancer as well as growth and behavioral defects. DNA 
methylation is catalyzed by DNA (cytosine-5)-methyltran- 
sferases (DNMTs), is initiated in the germ line and then further 
modified during early embryo development. In the field of 
male-mediated developmental toxicity, adverse effects on 
the offspring in animal studies often occur at levels too high 
to be accounted for by mutagenesis, leading to the suggestion 
that alternative mechanisms, including epigenetic processes, 
may be affected. 
Recent studies have reported that male-mediated effects on 
the progeny can be passed across generations and have 
implicated epigenetic mechanisms. In addition, a number of 
recent studies have linked the use of assisted reproductive 
technologies with growth and genomic imprinting disorders 
in children; epigenetic processes appear to be involved as the 
imprinting disorders found were associated with DNA 
methylation abnormalities. However, in the latter studies it 
was unclear whether the birth defects were related to the 
underlying infertility or the treatments (i.e. ICSI, superovulation, 
culture conditions) being used. 
Since DNA methylation events and enzymes are well 
conserved across mammals, the rat and mouse have served 
as excellent models relevant to human studies. Using the 
rodent model, our results and those of others indicate that DNA 
methylation is highly regulated in the male germ line and 
implicate alterations in the enzymes involved in DNA 
methylation, the DNMTs, and DNA methylation, with 
abnormalities in germ cell as well as embryo development. 
The presentation will describe recent studies on the timing and 
mechanisms underlying the acquisition and mainteneance 
of DNA methylation patterns in gametes and early embryos 
as well as the consequences of altering these patterns. Three 
models relevant to male-mediated effects will be reviewed, 
DNMT deficiency, effects of cytosine analogues and defects 
in folate (methyl donor) pathways. 
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Health of children conceived through 
intracytoplasmic sperm injection, in vitro 
fertilization, and natural conception 
A.G. SUTCLIFFE 
Institute of Child Health, Royal Free and University College 
Medical School, University College London, Department of 
Community Child Health, 250 Euston Road, 
London, NW1 2PQ 
In vitro fertilisation has been carried out for nearly 30 years 
and in developed countries 1% or more of births are from 
assisted reproductive therapies (ART). These children now 
represent a significant proportion of the population but until 
recently little has been known about their health. 
Some of the morbidity associated with assisted reproductive 
therapies does not result from the techniques as such but result 
from the underlying health risks of being sub fertile. 
Much of the increased risk associated with ART is related to 
higher birth order. However, there are apparent specific 
increased risks of intrauterine and subsequent perinatal 
problems, and urogenital malformations in boys, even in 
singleton ART infants. There is no apparent increase in 
problems within families. 
Long term follow-up of ART children to reproductive age and 
beyond is necessary. 
Keywords : childhood, assisted reproduction, outcome 
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Gene regulation in spermatogenesis and 
spermiogenesis - insights and implications for 
human infertility 
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No abstract provided. 
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Stem cells in spermatogenesis 
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Dept of Histology and Medical Embryology, University of 
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The highly efficient process of sperm production is dependent 
on proper hormone balance, local cellular interactions and, 
more importantly, on the biological activity of spermatogonial 
stem cells (SSCs), the stem cells of germline. Because of the 
ability to transmit genes from one generation to the next, 
SSCs represent the only replicating, potentially totipotent, 
population of cells in the adult body. A major breakthrough in 
understanding SSC biology was represented by the successful 
demonstration of spermatogonial transplantation and 
subsequent proliferation and differentiation of the transplanted 
cells in the recipient animal (1). Germ cell transplantation 
represents, to date, the only bioassy for SSCs and appears 
to have relevant potential applications. Manipulations of these 
cells in vitro, before transfer to a recipient subject, represents 
an opportunity to modify germline for generating transgenic 
experimental animals and introduction of new genes directly 
into the male germline could be of great interest for agricultural, 
zoological and clinical purposes. By FACS analysis and 
transplantation technology, surface antigenic profile of SSCs 
has been partially defined, however none of the markers 
identified is specific for SSCs, since they are expressed also 
by other germ cells and/or by somatic cells in the testis (2). 
Using Hoechst staining of isolated seminiferous tubule cells 
and FACS analysis, we were able to identify a testis "side 
population" (T-SP) population that, by transplantation 
technology, we demonstrated to be enriched in stem cell 
activity, evaluated 2 months after transplantation (3). Further 
characterization of T-SP SSCs by double vital staining with 
Hoechst and rhodamine, allowed us to understand that T-SP 
SSCs represent only a subset of SSCs and that a variety a 
SSC subpopulations, possibly endowed with different functional 
properties, could exist (4). It has been demonstrated that a 
combination of growth factors, such as GDNF, bFGF and 
EGF, induces the proliferation of spermatogonia with stem cell 
potential in vitro, thus providing the possibility to manipulate 
SSC genome. Transgenic mice and rats have been produced 
by retroviral infection of SSC (5) and, more recently, 
homologous recombination has been demonstrated to be 
feasible in mouse SSC (6). On this direction, we analyzed the 
feasibility of the in vitro Cre delivery to germ cells in order to 
obtain gene inactivation in stem cell germline (7). 
Conditional mutagenesis represents a powerful approach to 
analyze gene functions in mammalian cells. Site-specific 
recombinases such as the bacteriophage P1 recombinase Cre 
have been used to induce gene modification in a spatial 
and/or temporal manner (8). However, the use of site-specific 
recombination in genetic studies is limited by difficulties to 
express the recombinase in cells at the desired time and 
place. Recently a new tool for the in vitro deletion of IoxP 
flanked genes has been described. In this approach 
enzymatically active cell-permeable Cre recombinase is 
delivered to cultured target cells (9). The HTNC (HIS-TAT-NLS- 
CRE) recombinase has been shown to induce deletion of 
Iox-flanked gene in about 90% of ES cells or primary 
splenocytes (9). Genetic analysis in spermatogonial stem 
cells (SSC) is highly warranted but, presently, no Cre transgenic 
mice are available to perform conditional gene inactivation in 
postnatal SSC. 
To test if HTNC induces conditional gene inactivation in germ 
cells, we thought o treat germ cells isolated from ROSA26R 
mice and to detect recombination events by means of germ 
cell transplantation. Genetic analysis has demonstrated that 
after transplantation, donor-derived spermatogenic olonies 
originate from a single SSC thus germ cell progeny inherit he 
founder SSC genotype (1). We anticipated that recombination 
events occurring in HTNC-transduced SSC will generate 
colonies of donor-derived spermatogenesis where germ cell 
progeny bear the same recombination events. Recombinant 
colonies would therefore be easily recognizable as blue 
colonies in the recipient testis after X-gal staining owing to the 
activation of the ROSA 26R locus. 
Germ cells were isolated from adult ROSA26R mice and 
enriched in SSC by Percoll purification (10). Germ cell aliquots 
were treated in vitro with HTNC and transplanted in the testis 
of busulfan-treated recipient mice. Two months after 
transplantation, animals were sacrificed and testis analyzed 
to detect donor-derived blue colonies generated from modified 
SSC. Donor-derived blue colonies were found in 6 out of 11 
tranplanted testis. We have demonstrated, for the first time, 
the feasability of in vitro conditional gene inactivation in stem 
cell germline. This experimental strategy may be used to 
perform conditional gene inactivation in order to analyze gene 
functions in germ cells during spermatogenesis. The possibility 
to perform postnatal gene inactivation may be relevant for the 
study of Iox-flanked genes whose inactivation is either 
embryonically lethal or interferes with prenatal germ cell 
development. This strategy may also be used to introduce 
stable genome modification in mice germline. 
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Pathophysiology of erectile dysfunction 
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In unicellular organism genetic information to the offspring is 
just duplicated, and therefore, subsequent generations are 
identical to the preceding ones (parthogenetic reproduction). 
It is, overall, a monotonic, asexual reproduction. The individual 
diversity of the more complex organisms derives from the 
development of sexual reproduction, which requires two 
distinct partners (the couple) having distinct phenotypic and 
behavioural futures (maleness and femaleness). 
Couple reproduction allows billiards of possibility to exchange 
genetic material and is of great evolutionary advantage and 
very favourable for species evolution. However, sexual 
reproduction between heterogeneous individuals carries 
patent risks. Although the couple reproduction geometrically 
increased genetic benefits, threats and problems are similarly 
amplified. In fact, due to partner interdependence, sexual 
reproduction can be problematic either for reproductive or 
for sexual reasons, resulting in one hand in couple infertility 
and in the other one in couple sexual dysfunction. In fact, 
couple sexual function should be viewed as the net result of 
the sexual fitness of both partners. 
Only few decades ago it was generally thought hat the majority 
of male sexual dysfunctions (including erectile dysfunction) 
were mostly related to psychological problems, and to anxiety 
in particular. Hence, at that time, the only recognized treatment 
was psychotherapeutic, i.e psychoanalysis and behavioral 
therapy. Nowadays, it is well recognized that this picture is 
limitative, as biological and relational domains, beside 
psychological components, have a relevant impact on male 
sexual response. Indeed, male sexual response can be seen 
as an integrated feed-forward interaction among an intra- 
psychic system (the individual's sexual identity and sense of 
well-being), a biological system (cardiovascular, hormonal, 
neuronal), and a relational system (the context for a sexual 
relationship). 
Understanding the relative contribution of each of these 
components is essential for a correct diagnostic and/or 
therapeutic approach to male sexual dysfunction and, in 
particular, to erectile dysfunction (ED). From a biological point 
of view, male sexual activity is essentially characterized by a 
T-driven synchronization of sexual desire, arising in the brain, 
and its transmission to the periphery, allowing penile erection. 
The most important pathway underlying the penile erection 
is the nonadrenergic/noncholinergic s gnalling, which through 
the release of nitric oxide (NO), leads to an intracellular 
increase of cyclic GMP (cGMP), the main secondary 
messenger mediating tumescence in the penis. Interestingly, 
both cGMP formation and degradation are affected by 
testosterone (T). Because T positively controls both the 
initiation (NOS) and the end (PDE5) of the erectile process, 
its net effect on erection might result even null. Hence, 
erections are still possible in hypogonadal conditions where 
a decreased cGMP formation, due to impaired NO production, 
is counterbalanced by a reduced cGMP hydrolysis. 
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